Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Dynamin 2 regulates biphasic insulin secretion and plasma glucose homeostasis
Fan Fan, Chen Ji, Yumei Wu, Shawn M. Ferguson, Natalia Tamarina, Louis H. Philipson, Xuelin Lou
Fan Fan, Chen Ji, Yumei Wu, Shawn M. Ferguson, Natalia Tamarina, Louis H. Philipson, Xuelin Lou
View: Text | PDF
Research Article Endocrinology

Dynamin 2 regulates biphasic insulin secretion and plasma glucose homeostasis

  • Text
  • PDF
Abstract

Alterations in insulin granule exocytosis and endocytosis are paramount to pancreatic β cell dysfunction in diabetes mellitus. Here, using temporally controlled gene ablation specifically in β cells in mice, we identified an essential role of dynamin 2 GTPase in preserving normal biphasic insulin secretion and blood glucose homeostasis. Dynamin 2 deletion in β cells caused glucose intolerance and substantial reduction of the second phase of glucose-stimulated insulin secretion (GSIS); however, mutant β cells still maintained abundant insulin granules, with no signs of cell surface expansion. Compared with control β cells, real-time capacitance measurements demonstrated that exocytosis-endocytosis coupling was less efficient but not abolished; clathrin-mediated endocytosis (CME) was severely impaired at the step of membrane fission, which resulted in accumulation of clathrin-coated endocytic intermediates on the plasma membrane. Moreover, dynamin 2 ablation in β cells led to striking reorganization and enhancement of actin filaments, and insulin granule recruitment and mobilization were impaired at the later stage of GSIS. Together, our results demonstrate that dynamin 2 regulates insulin secretory capacity and dynamics in vivo through a mechanism depending on CME and F-actin remodeling. Moreover, this study indicates a potential pathophysiological link between endocytosis and diabetes mellitus.

Authors

Fan Fan, Chen Ji, Yumei Wu, Shawn M. Ferguson, Natalia Tamarina, Louis H. Philipson, Xuelin Lou

×

Figure 7

Strong defect in CME and abnormal accumulation of endocytic intermediates in Dnm2 KO β cells.

Options: View larger image (or click on image) Download as PowerPoint
Strong defect in CME and abnormal accumulation of endocytic intermediate...
(A) Impaired transferrin uptake in Dnm2 KO β cells. Representative images after 10 minutes of transferrin uptake. (B) Relative changes of fluorescence intensity (n = 3 independent experiments, 6–12 β cells were analyzed from each group in each experiment; P < 0.01, 2-tailed t test). (C) Accumulated endocytic intermediates (arrows) adjacent to the PM in KO cells. Two clathrin-coated vesicles interlinked together through a narrow membrane tubule (arrowhead) are shown in the inset. (D and E) A gallery of endocytic intermediates from Dnm2 KO and control cells. Note the CCPs with elongated necks/tubules in KO. (F) Significant increase of CCPs in Dnm2 KO cells at rest (n = 22 and 36 EM sections for control and KO) and after 20 mM glucose stimulation (n = 29 and 20 for control and KO cells, respectively) (P < 0.005, 2-tailed t test). (G) 3D reconstruction of endocytic profiles in a Dnm2 KO β cell using EM tomography. Cells were stimulated with 20 mM glucose for 20 minutes at 37°C before fixation. Note the abundant CCPs (red) and the elongated, narrow tubules (light green) that connected the CCPs to the PM (dark green) directly or through a membrane expansion. (H and I) Simple CCPs with elongated tubules connected to the cell surface. (J–M) Complex structures of endocytic intermediates that connected to PM with large, branched membrane vacuoles. Scale bars: 2 μm (A); 200 nm (C and G); 100 nm (C, inset, D, and E); 50 nm (H–M). **P < 0.01, ***P < 0.005.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts